Fatalities report spurs UK action on catheters
This article was originally published in Clinica
The UK Medical Devices Agency (MDA) is to discuss with catheter manufacturers ways of improving the radio-opacity of the tip. The move by the Department of Health (DoH) is among a series of measures being adopted in response to an investigation into four neonatal deaths due to cardiac tamponade associated with central venous catheterisation. The complication has revealed the need to carefully monitor the positioning of the catheter during insertion.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.